ELAVL1 and lip and oral cavity carcinoma: Interestingly, recent studies have shown that HuR knockdown attenuates the oncogenic potential of oral cancer cells [21], whereas a number of studies implicate HuR in the tumourigenesis and progression of head and neck carcinomas.